PANCREATIC ADENOSQUAMOUS CARCINOMA
Clinical trials for PANCREATIC ADENOSQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC ADENOSQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Timing of chemo could be key in pancreatic cancer fight
Disease control OngoingThis study tests whether giving chemotherapy both before and after surgery (perioperative) works better than giving it only after surgery (adjuvant) for people with pancreatic cancer that can be surgically removed. About 358 participants will receive a combination of standard che…
Matched conditions: PANCREATIC ADENOSQUAMOUS CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 17, 2026 04:33 UTC
-
New Three-Drug cocktail targets genetic weakness in tough pancreatic cancer
Disease control OngoingThis study compares a three-drug chemotherapy combination (nab-paclitaxel, gemcitabine, plus cisplatin) against the standard two-drug combination (nab-paclitaxel plus gemcitabine) for people with metastatic pancreatic cancer that has spread to other parts of the body. Participant…
Matched conditions: PANCREATIC ADENOSQUAMOUS CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 15, 2026 11:53 UTC